Cogent Biosciences, Inc. (COGT)

39.34 +0.16 (+0.41%) USD  |  NASDAQ  |  Feb 25, 14:57
More

Cogent Biosciences Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. --
Sarepta Therapeutics, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade